These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Metabolic syndrome and bariatric surgery in stone disease etiology. Tasca A Curr Opin Urol; 2011 Mar; 21(2):129-33. PubMed ID: 21191301 [TBL] [Abstract][Full Text] [Related]
44. [Reactive-dystrophic processes in salivary glands (sialoadenoses) running on the background of metabolic syndrome]. Afanas'ev VV; Striuk RI; Arutiunian SE; Eliseeva LV; Bychkov RA Stomatologiia (Mosk); 2011; 90(4):49-53. PubMed ID: 21983616 [TBL] [Abstract][Full Text] [Related]
46. Obesity and the insulin resistance syndrome. Dunger DB Arch Dis Child; 2005 Jan; 90(1):1. PubMed ID: 15613499 [No Abstract] [Full Text] [Related]
47. Animal models for assessing the impact of natural products on the aetiology and metabolic pathophysiology of Type 2 diabetes. Asrafuzzaman M; Cao Y; Afroz R; Kamato D; Gray S; Little PJ Biomed Pharmacother; 2017 May; 89():1242-1251. PubMed ID: 28320091 [TBL] [Abstract][Full Text] [Related]
48. Diabetes: Turning down galectin 3 to combat insulin resistance. Kingwell K Nat Rev Drug Discov; 2016 Dec; 16(1):18. PubMed ID: 28031565 [No Abstract] [Full Text] [Related]
55. Insulin resistance and metabolic syndrome: mechanisms and consequences. Schmidt AM Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1753. PubMed ID: 22815339 [No Abstract] [Full Text] [Related]
56. Interplay of vascular phenotype and metabolic phenotype in populations with or without type 2 diabetes. Bosevski M Stroke; 2008 Nov; 39(11):e175; author reply e176. PubMed ID: 18802203 [No Abstract] [Full Text] [Related]